SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-165305
Filing Date
2022-06-01
Accepted
2022-06-01 17:01:27
Documents
2
Group Members
FLAGSHIP PIONEERING FUND VII GENERAL PARTNER LLCFLAGSHIP PIONEERING FUND VII, L.P.FLAGSHIP PIONEERING, INC.FLAGSHIP V VENTURELABS RX FUND, L.P.FLAGSHIP VENTURELABS IV LLCFLAGSHIP VENTURELABS V LLCFLAGSHIP VENTURELABS V MANAGER LLCFLAGSHIP VENTURES FUND IV

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d339004dsc13da.htm SC 13D/A 324146
2 EX-99.1 d339004dex991.htm EX-99.1 26624
  Complete submission text file 0001193125-22-165305.txt   353220
Mailing Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund V, L.P. (Filed by) CIK: 0001627639 (see all company filings)

IRS No.: 611749444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 781 479 2974
Evelo Biosciences, Inc. (Subject) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90477 | Film No.: 22988146
SIC: 2834 Pharmaceutical Preparations